36P Eligibility and outcomes in phase I clinical trials testing targeted therapy, immunotherapy and combinations: A single-institution study
Titel:
36P Eligibility and outcomes in phase I clinical trials testing targeted therapy, immunotherapy and combinations: A single-institution study
Auteur:
Marra, A. Morganti, S. Viale, G. Tarantino, P. Trapani, D. Ferraro, E. Zagami, P. Repetto, M. Nicolò, E. D'Amico, P. Trillo Aliaga, P. Massaro, M.A. Busacca, C. Minchella, I. Belli, C. Locatelli, M. Mazzarella, L. Esposito, A. Criscitiello, C. Curigliano, G.